Using drug scheduling to manage adverse events associated with hedgehog pathway inhibitors for basal cell carcinoma

Basal cell carcinoma (BCC) is the most common malignancy and form of skin cancer worldwide; advanced BCC, either as locally advanced BCC (laBCC) or metastatic BCC (mBCC), can cause substantial tissue invasion and morbidity. Until the recent availability of the hedgehog pathway inhibitors (HHIs) soni...

Descripción completa

Detalles Bibliográficos
Autores principales: Lear, John T., Dummer, Reinhard, Guminski, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711575/
https://www.ncbi.nlm.nih.gov/pubmed/34966484
http://dx.doi.org/10.18632/oncotarget.28145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711575/
https://www.ncbi.nlm.nih.gov/pubmed/34966484
http://dx.doi.org/10.18632/oncotarget.28145

Ejemplares similares